Health-related quality of life following surgical menopause and following gonadotrophin-releasing hormone analogue-induced pseudomenopause

By Bhattacharya Sudhindra Mohan  

Gynecological Endocrinology, Vol. 25, Iss. 9, 2009-09 ,pp. : 621-623

Informa Healthcare

Access to resources Recommend Favorite

Treatment of uterine leiomyomas with luteinizing hormone-releasing hormone antagonist Cetrorelix.

By Gonzalez-Barcena D   Alvarez R B   Ochoa E P   Cornejo I C   Comaru-Schally A M   Schally A V   Engel J   Reissmann T   Riethmüller-Winzen H  

Human Reproduction, Vol. 12, Iss. 9, 1997-09 ,pp. : 2028-2035

Oxford University Press

Access to resources Recommend Favorite

Serum luteinizing hormone, follicle-stimulating hormone and oestradiol pattern in women undergoing pituitary suppression with different gonadotrophin-releasing hormone analogue protocols for assisted reproduction

By Manna Claudio   Rahman A   Sbracia M   Pappalardo S   Mohamed EI   Linder R   Nardo LG  

Gynecological Endocrinology, Vol. 20, Iss. 4, 2005-04 ,pp. : 188-194

Informa Healthcare

Access to resources Recommend Favorite

Effect of profound suppression of luteinizing hormone during treatment with gonadotrophin-releasing hormone analogue and purified follicle stimulating hormone upon development of cryopreserved embryos

By Rekha P   Mowat L   Jamieson ME   Yates RWS   Fleming R  

Human Reproduction, Vol. 13, Iss. 3, 1998-03 ,pp. : 696-698

Oxford University Press

Access to resources Recommend Favorite

Growth-Inhibitory Actions of Analogues of Luteinizing Hormone Releasing Hormone on Tumor Cells

By Emons G.   Ortmann O.   Schulz K.-D.   Schally A.V.  

Trends in Endocrinology and Metabolism, Vol. 8, Iss. 9, 1997-11 ,pp. : 355-362

Elsevier

Access to resources Recommend Favorite